Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lukas Uebbing
Observed name:
L Uebbing
Institution:
Engelhard Arzneimittel (Germany)
Observed institution:
Engelhard Arzneimittel (Germany)
OpenAlex ID:
A5092452011
Real-World-Daten zeigen Mehrwehrt von Cineol gegenüber Nasenspray-Monotherapie bei Rhinosinusitis
2023
·
Simon Braun
, Lukas Uebbing
·
Evidence of self-medication
·
1
PDF
Treatment of rhinosinusitis with 1,8-cineole and nasal spray under real- world conditions: influence on the quality of life
2023
·
Lukas Uebbing
, Simon Braun
, et al.
·
Planta Medica
A meta-analysis confirms the efficacy of ivy leaves dry extract EA 575 as treatment of acute cough in adults
2023
·
Lukas Uebbing
, Ralph Mösges
·
Planta Medica
Ivy leaf dry extract EA 575 is the first phytotherapeutic drug known to mediate biased β2-receptor signaling
2023
·
Fabio Meurer
, Janka Schulte-Michels
, et al.
·
Planta Medica
Eine Metaanalyse untermauert die Evidenz von Efeublätter-Trockenextrakt EA 575® in der Behandlung von akutem Husten bei Erwachsenen
2023
·
R Mösges
, L Uebbing
, et al.
·
Zeitschrift für Phytotherapie
Acceso a la máxima clase de evidencia: un metaanálisis corrobora la evidencia de EA 575® en la tos aguda
2023
·
Lukas Uebbing
, Simon Braun
·
Evidence for Self-Medication
PDF
Aufstieg in die höchste Evidenzklasse: Metaanalyse untermauert die Evidenz von EA 575® bei akutem Husten
2023
·
Lukas Uebbing
, Simon Braun
·
Evidence of self-medication
PDF
Promoted to the highest evidence class: meta-analysis supports the evidence for EA 575® in treating acute cough
2023
·
Lukas Uebbing
, Simon Braun
·
Evidence for Self-Medication
PDF
Show more works
View as search
Works count:
8
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type